“MTRC is an expert in the market access of medical devices. They are updated about changes and know the realities that impact the business. They are fair and honest with their advice and trustworthy with discussions and deliverables. It is a pleasure to work with MTRC, whom we consider a reliable partner.“
Zenichi Ihara, Director, Health Economics and Reimbursement EMEA, CRM, EP, HF, Abbott
"MTRC has provided us with invaluable insights and guidance on how best to navigate reimbursement and health technology processes in key European markets. MTRC has accumulated an unparalleled knowledge base that puts them in a unique position. Their email subscription service is a very helpful tool for staying up to date on market access news, where changes are constant. The team is a pleasure to work with and consistently brings practical value to projects."
Casper Barsoe, Vice President, Market Access, BIOTRONIK SE & Co KG
“Oleg and the team at MTRC provided us with a very comprehensive analysis with key sights and recommendations for a practical and feasible reimbursement approach for our product. MTRC took the time to understand our clinical area and brought clinical consultants on board during the activity for an in-depth understanding of our field of work. I recommend MTRC to my peers and the institutions we are affiliated with.”
Sarusha Pillay, Commercial Lead, pHetalSafe (pre-spinout team) at the University College Cork
“MTRC takes time to fully understand our questions and objectives and delivers insightful, professional, and valuable results accordingly.”
Michael Morseon, Former Senior Director, Healthcare Economics & Market Access, CooperSurgical
“I have used the services of MTRC a number of times in different positions during my career and have found them to be a leading authority on Health Technology Assessment and Reimbursement marketing research, even for the most obscure of clinical case types. They are fast, efficient, transparent, professional, and the quality of their reporting is second to none. I highly recommend them as a research firm on anything reimbursement or HTA related for the European Continent.”
Michael van Driel, Vice President Global Business Development and General Manager, CBM Lifemotion
“Working with MTRC was a great experience. Their expertise and professionalism were evident in every step of the project. The team was highly responsive and delivered clear and timely results. I highly recommend MTRC for any project that requires a clear reimbursement strategy and local reimbursement analysis.”
Itay Jacob, VP Sales & Marketing, Mego Afek
“I’ve just completed my 2nd experience of collaboration with MTRC, both on the MedTech and Pharma reimbursement environment.
I have come back to MTRC because of the speed of execution (compared to other vendors), the acumen in the preparatory work, and the accuracy of the report.
I also very much value their insights on policy recommendations, helping me to navigate very complex reimbursement systems at the EU level.
Definitely recommended!”
Andrea Minotto, Director Global Market Access, Bracco
“MTRC, led by Oleg Borisenko and his team, has been an invaluable partner to InVera Medical over the past several years. Their expertise in European reimbursement, market analysis, and budget impact assessments has consistently provided us with high-quality insights that have been crucial for our strategic decisions. The team's clear communication, reliability, and ability to deliver on time have made them a trusted consultant in our journey. We highly recommend MTRC for their exceptional service and expertise.”
Stephen Cox, CEO, Co-Founder, InVera Medical
"MTRC exceeded our expectations for our university medical device technology. Beyond delivering expert reimbursement analysis and market access strategies for our target geographies, they proactively identified additional optimal markets we hadn't considered. Their team's accessibility and patience in explaining complex analyses made them true partners in our project's development. For anyone seeking thorough, strategic market access guidance, MTRC is an outstanding choice."
Justina Ugwah, Commercial lead, CLISTEPROBE, Tyndall National Institute
"Invizius is a clinical-stage biotech developing second-generation complement therapies addressing serious unmet needs for patients on extracorporeal circuit therapies. For our company to be successful, it is important to develop reimbursement solutions and market access strategies to allow for fast and widespread adoption of our breakthrough technology. MTRC provided us with a clear market access reimbursement strategy specifically designed around the specificities and patient benefits of our lead product H-Guard. This individualized approach is unique among consultants and has proven invaluable. We would highly recommend MTRC for anyone seeking advice on European market access."
Eric Beard, Chairman, Invizius
